+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygous mutations of TYMP as underlying causes of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)



Compound heterozygous mutations of TYMP as underlying causes of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)



Molecular Medicine Reports 8(1): 17-22



Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), an autosomal recessive multiorgan disease, frequently associated with mutations in the thymidine phosphorylase (TYMP) gene. TYMP encodes thymidine phosphorylase (TP), which has an essential role in the nucleotide salvage pathway for mitochondrial DNA (mtDNA) replication. This study reports an MNGIE patient with novel compound heterozygous missense mutations (Thr151Pro and Leu270Pro) in TYMP. Each mutation was inherited from one parent. Neither mutation was found in the controls and the mutation sites were well conserved between different species. Neither large deletion nor causative point mutations were found in the mtDNA. The patient presented with MNGIE symptoms, including gastrointestinal discomfort, external ophthalmoplegia, pigmentary retinopathy and demyelinating type diffuse sensory motor polyneuropathy. The patient demonstrated an early-onset but mild phenotype, with 9.6% TP activity; therefore, patients with these compound heterozygous mutations may exhibit a mild phenotype with a variable onset age according to TP activity level.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269150

Download citation: RISBibTeXText

PMID: 23685548

DOI: 10.3892/mmr.2013.1479


Related references

Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Neuromuscular Disorders 19(2): 151-154, 2008

Compound mutations of PEO1 and TYMP in a progressive external ophthalmoplegia patient with incomplete mitochondrial neurogastrointestinal encephalomyopathy phenotype. Genes & Genomics 33(4): 431-437, 2011

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype in a patient with a novel heterozygous POLG mutation. Journal of Neurology 261(9): 1818-1819, 2015

Leukoencephalopathy with a case of heterozygous POLG mutation mimicking mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Journal of Clinical Neuroscience 2018, 2018

Thymidine phosphorylase gene mutations cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Internal Medicine 45(19): 1103, 2006

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. Journal of Neurology 259(5): 862-868, 2012

Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients. European Journal of Human Genetics 11(1): 102-104, 2003

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Casopis Lekaru Ceskych 145(8): 665-670, 2006

MNGIE (mitochondrial neurogastrointestinal encephalomyopathy). Ryoikibetsu Shokogun Shirizu 2001(36): 160-163, 2001

A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy. Clinical Neurology and Neurosurgery 111(8): 691-694, 2009

Eye movement changes in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Journal of the Neurological Sciences 350(1-2): 107-109, 2015

Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1). Journal of Clinical Medicine 7(11), 2018

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10(1): 8-17, 2004

Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a Novel TYMP Mutation: The Need for Early Diagnosis. Case Reports in Neurology 4(3): 248-253, 2013

Possible toxicity of tuberculostatic agents in a patient with a novel TYMP mutation leading to mitochondrial neurogastrointestinal encephalomyopathy. Journal of Neurogenetics 27(1-2): 19-22, 2014